memantine has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A mouse model of Lafora disease (Epm2b-/-) was used to check the putative beneficial effect of different drugs aimed to ameliorate the alterations in glutamatergic transmission and/or neuroinflammation present in the model." | 1.72 | Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model. ( Campos, Á; Heredia, M; Mollá, B; Sanz, P, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mollá, B | 1 |
| Heredia, M | 1 |
| Campos, Á | 1 |
| Sanz, P | 1 |
1 other study available for memantine and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model.
Topics: Adolescent; Animals; Disease Models, Animal; Dual-Specificity Phosphatases; Humans; Lafora Disease; | 2022 |